Position in PBLS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$134,646,660
New position
Shares Held
4,919,498
first reported quarter
Ownership
3.98%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#5
of 79 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alphabet Inc. holds $884,358,161 across 13 Biotechnology names. PBLS ranks #2 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,946,619 | $551,842,806 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
This page
|
4,919,498 | $134,646,660 | |
| 3 | PRME |
Prime Medicine, Inc.
|
16,562,498 | $61,115,617 | |
| 4 | MAZE |
Maze Therapeutics, Inc.
|
1,388,583 | $41,435,316 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
1,410,029 | $26,381,642 | |
| 6 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,823,126 | $21,512,220 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
321,604 | $11,037,449 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
241,264 | $10,352,638 |
All Filings in PBLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,646,660 | 4,919,498 | Shares | Defined | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||